SCHEMBL26465870

SCHEMBL26465870

CCN1CCO[C@@H](CN(C)CC(C)C)C1

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.37
CCR2 P41597 1/20 0.34
KCNH2 Q12809 1/20 0.34
DRD3 P35462 1/20 0.33
PIK3CD O00329 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22856067 1.00 HRH3 (0.37) HRH3CCR2KCNH2DRD3PIK3CD
SCHEMBL22848948 1.00 HRH3 (0.37) HRH3CCR2KCNH2DRD3PIK3CD
SCHEMBL21106666 0.88 PIK3CD (0.38) PIK3CD
SCHEMBL22837733 0.88 PIK3CD (0.38) PIK3CD
SCHEMBL24379841 0.88 PIK3CD (0.38) PIK3CD
SCHEMBL24509130 0.87
SCHEMBL23559954 0.86 EPHA2 (0.33) DRD3
SCHEMBL22856341 0.86 EPHA2 (0.33) DRD3
SCHEMBL22837759 0.85 GBA1 (0.33)
SCHEMBL22837765 0.85 GBA1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192578-A1 PROTEIN DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed
WO-2023077077-A1 RNA DEGRADERS AND USES THEREOF ARRAKIS THERAPEUTICS, INC. (US) 2023-05-04 WO disclosed